title: Should aspirin be discontinued before coronary artery bypass surgery?
authors.affiliation: Division of Cardiac Surgery, McMaster University, Hamilton, Canada. sunjc2@mcmaster.ca
authors.forename: Jack C J
authors.initials: JC
authors.lastname: Sun
authors.forename: Mark A
authors.initials: MA
authors.lastname: Crowther
authors.forename: Theodore E
authors.initials: TE
authors.lastname: Warkentin
authors.forename: Andre
authors.initials: A
authors.lastname: Lamy
authors.forename: Kevin H T
authors.initials: KH
authors.lastname: Teoh
mesh_terms: D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy / Q000601:surgery; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion / Q000706:statistics & numerical data; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000517:prevention & control; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D008297:Male; D011300:Preoperative Care; D016032:Randomized Controlled Trials as Topic
chemical_list: D016861:Cyclooxygenase Inhibitors; D005343:Fibrinolytic Agents; D001241:Aspirin